Medscape December 11, 2024
Miriam E. Tucker

The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) beyond weight loss, management of metabolic dysfunction-associated liver disease (MAFLD), plus a strong endorsement for drinking water and much more.

The Standards of Care — 2025 were published December 9 as a supplement to Diabetes Care. The standards “incorporate the latest information from clinical trial data and knowledge of diabetes management into a comprehensive guidelines document that will assist physicians in managing patients with diabetes in their practices,” Mandeep Bajaj, MBBS, ADA’s President, Medicine & Science, told Medscape Medical News.

In an interview, Bajaj highlighted some of the most important...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma / Biotech, Provider, Technology, Wearables
House expected to consider CR to fund government through Sept. 30, extend key health care provisions
Sagora CEO: After Growing 30% To Surpass 80 Communities, Company Prepares For Next Steps
Calvary Hospital’s New President: Workforce, Research Initiatives Keys to ‘Reinvigorating’ Hospice Care
3 million Americans live where even telehealth can't reach: 6 notes
Headways and hurdles: How AI is shaping the future of medicine

Share This Article